Macquarie Group Ltd. continued to hold its stake in Henry Schein Inc. (NASDAQ:HSIC) during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 800 shares of the company’s stock at the end of the second quarter. Macquarie Group Ltd.’s holdings in Henry Schein were worth $141,000 at the end of the most recent quarter.
Several other hedge funds also recently bought and sold shares of the company. Commonwealth Equity Services Inc increased its stake in Henry Schein by 15.3% in the first quarter. Commonwealth Equity Services Inc now owns 5,119 shares of the company’s stock worth $884,000 after buying an additional 678 shares in the last quarter. Ngam Advisors L.P. bought a new stake in Henry Schein during the first quarter worth about $1,749,000. TIAA CREF Investment Management LLC increased its stake in Henry Schein by 5.8% in the first quarter. TIAA CREF Investment Management LLC now owns 296,985 shares of the company’s stock worth $51,269,000 after buying an additional 16,247 shares in the last quarter. FDO Partners LLC bought a new stake in Henry Schein during the first quarter worth about $234,000. Finally, Franklin Resources Inc. increased its stake in Henry Schein by 12.6% in the first quarter. Franklin Resources Inc. now owns 476,789 shares of the company’s stock worth $82,308,000 after buying an additional 53,203 shares in the last quarter. 91.98% of the stock is owned by institutional investors.
Henry Schein Inc. (NASDAQ:HSIC) opened at 160.04 on Wednesday. The stock has a market cap of $13.09 billion, a PE ratio of 27.11 and a beta of 1.05. The firm has a 50 day moving average of $162.59 and a 200-day moving average of $170.62. Henry Schein Inc. has a 52-week low of $136.01 and a 52-week high of $183.00.
Henry Schein (NASDAQ:HSIC) last issued its earnings results on Thursday, August 4th. The company reported $1.64 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.63 by $0.01. Henry Schein had a net margin of 4.42% and a return on equity of 17.84%. The firm earned $2.87 billion during the quarter, compared to analyst estimates of $2.85 billion. During the same quarter in the prior year, the business earned $1.46 earnings per share. Henry Schein’s revenue for the quarter was up 9.3% on a year-over-year basis. Equities analysts anticipate that Henry Schein Inc. will post $6.57 earnings per share for the current fiscal year.
A number of analysts have recently issued reports on HSIC shares. Zacks Investment Research downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a report on Tuesday, July 5th. Bank of America Corp. initiated coverage on shares of Henry Schein in a research report on Monday, September 12th. They issued a “buy” rating and a $185.00 target price on the stock. Finally, Robert W. Baird reiterated an “outperform” rating and issued a $176.00 target price (up previously from $175.00) on shares of Henry Schein in a research report on Tuesday. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $157.92.
In related news, Director Paul Brons sold 3,381 shares of the company’s stock in a transaction on Monday, August 29th. The shares were sold at an average price of $164.03, for a total transaction of $554,585.43. Following the completion of the transaction, the director now owns 13,715 shares in the company, valued at $2,249,671.45. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 1.27% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.